Future oncology (London, England)

Future Oncol · ISSN (e) 1744-8301 · 5 papers in corpus
2025
doi:10.1080/14796694.2025.2530920 ·PMID:40650990

Endometrial cancer (EC) is intricately linked to obesity, with metabolic reprogramming increasingly established to drive oncogenic transformation and influence treatment outcomes. Implementation of early detection strategy significantly red…

2025
doi:10.1080/14796694.2025.2546281 ·PMID:40843714

PurposeA retrospective observational study was conducted to investigate the predictors for recurrence of stage I-II endometrial cancer after surgical treatment.Methods130 stage I-II endometrioid carcinoma patients receiving laparoscopic sur…

review 2015
doi:10.2217/fon.15.45 ·PMID:25952785

Ovarian clear cell carcinoma is a distinct subtype of epithelial ovarian cancer, characterized by an association with endometriosis, glycogen accumulation and resistance to chemotherapy. Key driver events, including ARID1A mutations and HNF…

2012
doi:10.2217/fon.11.135 ·PMID:22149035

The goal of effective population-based screening for ovarian cancer remains elusive despite intense efforts aimed at improving upon biomarker and imaging modalities. While dozens of potential serum biomarkers for ovarian cancer have been id…

2006
doi:10.2217/14796694.2.4.469 ·PMID:16922614

The prognosis of malignancies of the upper gastrointestinal tract is poor if early diagnosis is missed. Therefore, a rapid in vivo diagnosis of early cancer and premalignant lesions is highly important for successful therapy. Confocal laser…